Published in Hepatitis Weekly, May 8th, 1995
Because it would be administered in vivo, unique features of DNA-based immunization in skeletal muscle include the possibility of sustained delivery of antigen at low levels to the immune system, stated Heather L. Davis, Ph.D., associate professor, University of Ottawa, and Principal Investigator, Loeb Medical Research Institute, Ottawa, Ontario, Canada at the Hepatitis - Latest Advances in the Diagnosis, Prevention and Treatment of HBV and HCV meeting April 20-21, 1995, in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.